Elevance Health Inc. (ELV)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for ELV is $436.34, 1.9% above the last close of $428.26 on Oct 16, 2026; targets range from $373.78 to $486.40. Rating consensus: Buy.
Snapshot
- P/E19.0x
- P/E vs sector-32.4%
- P/E vs own+34.0%
- Target upside+1.9%
- ConsensusBuy
- Market cap$92.88B
- FCF yield+6.8%
- InsidersNone in 90d
- Earnings in5d
- News1.00
Why it moved
Elevance Health Inc. (ELV) was flat on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%.
1 story on the day (30-day average 0.3).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $428.26 · +25.4% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50↓ in ~5d
- RSI67
- Support-2.0%
- Resistance—
- Off 52w high0.0%
- Off ATH-20.7%
- 52w range$428.26
- Bollingerupper half
- MACD3.66
- ATR+2.4%
- Volume1.0x
Analyst price targets
19 firms with a target in the last 12 months · last close $428.26 · as of Oct 16, 2026
Strong buy 3 · Buy 12 · Hold 8 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +1.4% year over year, free cash flow 3.2% of revenue, operating margin 4.1%.
| Q2 FY2026 | Jun 30, 2026 | $50.47B | 6.71 | $1.63B | 89.1% | 4.1% | 2.9% |
| Q1 FY2026 | Mar 31, 2026 | $50.18B | 8.00 | $4.1B | 18.1% | 5.3% | 3.5% |
| Q4 FY2025 | Dec 31, 2025 | $49.75B | 2.47 | -$209M | 23.5% | 1.2% | 1.1% |
| Q3 FY2025 | Sep 30, 2025 | $50.71B | 5.32 | $775M | 24.8% | 3.5% | 2.3% |
| Q2 FY2025 | Jun 30, 2025 | $49.78B | 7.72 | $1.79B | 26.3% | 5.3% | 3.5% |
| Q1 FY2025 | Mar 31, 2025 | $48.89B | 9.61 | $821M | 27.8% | 6.4% | 4.5% |
| Q4 FY2024 | Dec 31, 2024 | $45.44B | 1.81 | $384M | 26.3% | 2.1% | 0.9% |
| Q3 FY2024 | Sep 30, 2024 | $45.15B | 4.36 | $2.35B | 27.0% | 3.8% | 2.3% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $401.43 | -1.3% | -7.4% | +14.6% | 22.9 | $360B | |
| 2 |  | $92.36 | -0.2% | -16.0% | +20.9% | 24.4 | $118B | |
| 3 |  | $458.84 | -2.1% | -15.4% | +2.1% | 15.4 | $99.34B | |
| 4 | | $428.26 | 0.0% | 0.0% | +1.9% | 19.0 | $92.88B | |
| 5 |  | $218.01 | -7.8% | -7.8% | -25.0% | — | $87.04B | |
| 6 |  | $302.30 | +1.2% | -0.2% | +10.9% | 12.5 | $79.88B | |
| 7 |  | $413.16 | -4.4% | -4.7% | +15.7% | 39.1 | $49.63B | |
| 8 |  | $69.16 | -1.9% | -1.9% | -0.5% | — | $34.16B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.